-
Intuitive Surgical's Q2 Performance Lauded By Bullish Analysts
Friday, July 19, 2019 - 10:23am | 927Robotic surgical system manufacturer Intuitive Surgical, Inc. (NASDAQ: ISRG) reported above-consensus second-quarter results Thursday. The Analysts Canaccord Genuity analyst Jason Mills maintained a Buy rating on Intuitive Surgical and lifted the price target from $575 to $610. Stifel...
-
Analysts Review Stryker's Q1: 'The Underlying Business Momentum Remains Strong'
Wednesday, April 24, 2019 - 3:24pm | 421Medical technology and orthopedic implant company Stryker Corporation (NYSE: SYK) reported an earnings beat Tuesday, and three sell-side analysts remain bullish on the stock. Stryker reported quarterly earnings of $1.88 per share, beating the consensus estimate of $1.84 and up about 12...
-
Raymond James Stays Bullish As Intuitive Surgical Falls On Quarterly Results: 'We Would Buy On Any Weakness'
Monday, April 22, 2019 - 1:57pm | 471Shares of robotic surgical systems maker Intuitive Surgical, Inc. (NASDAQ: ISRG) were tumbling below the $500 handle Monday for the first time since late January following the release of its quarterly results after the close Thursday. The Analyst Raymond James analyst Lawrence Keusch...
-
Teleflex Analyst Sees 'Sustainable Growth Profile' In Medical Device Manufacturer
Wednesday, March 27, 2019 - 11:17am | 367Consensus expectations for Teleflex Incorporated (NYSE: TFX) imply an improvement in revenue growth from an estimated 6.5 percent in 2019 to 7.2 percent in 2020, according to Raymond James. New product traction and the potential commencement of UroLift sales in Japan could drive a further...
-
Raymond James Lifts Cooper Companies Price Target After Q1 EPS Beat And Raise
Wednesday, March 6, 2019 - 10:42am | 329Medical supplier Cooper Companies Inc (NYSE: COO) outperformed first-quarter estimates on an operational basis, and its key account strategy should support share gains, according to Raymond James. The Analyst Raymond James’ Lawrence Keusch maintains an Outperform rating on Cooper...
-
GenMark Bulls Emboldened By Accelerated ePlex Panel Clearance
Thursday, December 27, 2018 - 11:24am | 356GenMark Diagnostics, Inc (NASDAQ: GNMK) surged 12 percent Wednesday after announcing FDA market clearance for its ePlex Blood Culture Identification Fungal Pathogen Panel. The news bolstered Raymond James' bullish thesis for the stock. The Analyst Raymond James analyst John Hsu ...
-
Morgan Stanley Turns Bullish On Haemonetics, Raymond James Moves To The Sidelines
Tuesday, January 2, 2018 - 2:19pm | 666Haemonetics Corporation (NYSE: HAE), a provider of blood and plasma services and supplies, may be benefiting from improved visibility on its transformation, according to Morgan Stanley. Raymond James also sounded upbeat on the medical technology name, with the view that Haemonetics has...
-
Medical Devices Industry Update (BAX, BCR, COO, MASI, HAE)
Tuesday, March 23, 2010 - 12:33pm | 330Analysts Lawrence Keusch and Konstantin Tcherepachenets at Morgan Keegan have released an update on the Medical Devices industry. After an approval for the healthcare reform bill by the House of Representatives on Sunday, the path is clear now for President Barack Obama to make it into a law. As a...